HEADER IMMUNE SYSTEM 13-OCT-15 5E7W TITLE X-RAY STRUCTURE OF HUMAN RECOMBINANT 2ZN INSULIN AT 0.92 ANGSTROM COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN; COMPND 3 CHAIN: A, C; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: HUMAN INSULIN A AND C CHAIN INSULIN WAS PURCHASED FROM COMPND 6 INSUGEN; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: INSULIN; COMPND 9 CHAIN: B, D; COMPND 10 ENGINEERED: YES; COMPND 11 OTHER_DETAILS: HUMAN INSULIN B AND D CHAIN INSULIN WAS PURCHASED FROM COMPND 12 INSUGEN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: INS; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: INS; SOURCE 13 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 4922 KEYWDS INSULIN, HUMAN, RECOMBINANT, HIGH-RESOLUTION, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR D.R.LISGARTEN,C.E.NAYLOR,R.A.PALMER,C.M.C.LOBLEY REVDAT 6 10-JAN-24 5E7W 1 LINK REVDAT 5 06-DEC-17 5E7W 1 JRNL REVDAT 4 15-NOV-17 5E7W 1 JRNL REVDAT 3 26-OCT-16 5E7W 1 REVDAT 2 19-OCT-16 5E7W 1 REVDAT 1 12-OCT-16 5E7W 0 JRNL AUTH D.R.LISGARTEN,R.A.PALMER,C.M.C.LOBLEY,C.E.NAYLOR, JRNL AUTH 2 B.Z.CHOWDHRY,Z.I.AL-KURDI,A.A.BADWAN,B.J.HOWLIN, JRNL AUTH 3 N.C.J.GIBBONS,J.W.SALDANHA,J.N.LISGARTEN,A.K.BASAK JRNL TITL ULTRA-HIGH RESOLUTION X-RAY STRUCTURES OF TWO FORMS OF HUMAN JRNL TITL 2 RECOMBINANT INSULIN AT 100 K. JRNL REF CHEM CENT J V. 11 73 2017 JRNL REFN ISSN 1752-153X JRNL PMID 29086855 JRNL DOI 10.1186/S13065-017-0296-Y REMARK 2 REMARK 2 RESOLUTION. 0.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL 2014/7 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : THIN SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 810 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 220 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 ANGLE DISTANCES (A) : NULL REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5E7W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-OCT-15. REMARK 100 THE DEPOSITION ID IS D_1000213709. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-SEP-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.2 - 6.4 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.77 REMARK 200 MONOCHROMATOR : BEAMLINE FIXED AT 16000KEV REMARK 200 OPTICS : DATA WERE COLLECTED AT 16000KEV REMARK 200 (0.77 ANGSTROM) AND 100 DEG K REMARK 200 WITH THE PILATUS 6M DETECTOR AS REMARK 200 CLOSE TO THE SAMPLE AS POSSIBLE REMARK 200 (179.5MM). THE EDNA STRATEGY WAS REMARK 200 USED TO OBTAIN A START ANGLE AND REMARK 200 180 DEG OF DATA WERE COLLECTED REMARK 200 WITH 0.1 DEG OSCILLATION AND REMARK 200 0.1S EXPOSURE. THE RESOLUTION OF REMARK 200 USEFUL DIFFRACTION DATA ACHIEVED REMARK 200 AND USED FOR STRUCTURE ANALYSIS REMARK 200 WAS 0.92 ANGSTROM. REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS FAST DP XIA 2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS FAST DP XIA 2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 58647 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.920 REMARK 200 RESOLUTION RANGE LOW (A) : 40.910 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.03400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.92 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 0.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.96700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3W7Y REMARK 200 REMARK 200 REMARK: NEEDLE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE CRYSTALS WERE PREPARED BY A BATCH REMARK 280 METHOD SIMILAR TO THAT OF BAKER ET AL, 1988 [1], MODIFIED AS REMARK 280 FOLLOWS: 0.01G OF INSULIN AS A FINE POWDER WAS PLACED IN A CLEAN REMARK 280 TEST TUBE; 0.02M HCL WAS ADDED TO DISSOLVE THE PROTEIN; ON REMARK 280 ADDITION OF 0.15 ML OF 0.15 M ZINC ACETATE THE SOLUTION BECAME REMARK 280 CLOUDY DUE TO PRECIPITATION OF THE PROTEIN; 0.3 ML OF ACETONE REMARK 280 AND THEN 0.5 ML OF TRISODIUM CITRATE TOGETHER WITH 0.8 ML OF REMARK 280 WATER WERE ADDED AND THE SOLUTION WENT CLEAR; THE PH WAS CHECKED REMARK 280 AND INCREASED WITH NAOH TO A PH BETWEEN 8 AND 9 FOR DIFFERENT REMARK 280 BATCHES, THUS ENSURING COMPLETE DISSOLUTION. IT WAS THEN REMARK 280 ADJUSTED TO THE REQUIRED VALUE OF PH 6.3. IF ANY SLIGHT REMARK 280 TURBIDITY OCCURRED, IT WAS REMOVED BY WARMING THE SOLUTION. THE REMARK 280 SOLUTION WAS THEN FILTERED USING A MILLIPORE MEMBRANE/ACETATE REMARK 280 CELLULOSE ACETATE FILTER. THIS REMOVES ANY NUCLEI WHICH WILL REMARK 280 ENCOURAGE PRECIPITATION OR FORMATION OF MASSES OF SMALL REMARK 280 CRYSTALS. THE SOLUTION WAS THEN WARMED TO 50 DEG C BY REMARK 280 SURROUNDING THE TEST TUBE WITH PREHEATED WATER IN A DEWAR. THIS REMARK 280 ALLOWED THE SOLUTION TO COOL SLOWLY TO ROOM TEMPERATURE. THE REMARK 280 TEST TUBE WAS LIGHTLY SEALED WITH CLING FILM; CRYSTALS FORMED REMARK 280 WITHIN A FEW DAYS AND WERE OF SUITABLE SIZE FOR X-RAY REMARK 280 DIFFRACTION WITHIN TWO WEEKS; THE TEST TUBE CONTAINING CRYSTALS REMARK 280 WAS KEPT AT 4 DEGC PRIOR TO DATA COLLECTION. THE CRYSTAL USED REMARK 280 FOR DATA COLLECTION WAS ABOUT 0.2 MM3., BATCH MODE, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.91000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.61940 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 11.28333 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 40.91000 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 23.61940 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 11.28333 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 40.91000 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 23.61940 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 11.28333 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 47.23880 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 22.56667 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 47.23880 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 22.56667 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 47.23880 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 22.56667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DODECAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 20360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -288.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 ZN ZN B 100 LIES ON A SPECIAL POSITION. REMARK 375 ZN ZN D 202 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 255 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 266 LIES ON A SPECIAL POSITION. REMARK 375 HOH D 351 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY C 1 CA - C - O ANGL. DEV. = -10.9 DEGREES REMARK 500 GLY C 1 CA - C - N ANGL. DEV. = 17.5 DEGREES REMARK 500 CYS C 11 CB - CA - C ANGL. DEV. = -12.7 DEGREES REMARK 500 THR D 27 CA - CB - CG2 ANGL. DEV. = 8.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 9 -127.30 -122.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 265 DISTANCE = 5.89 ANGSTROMS REMARK 525 HOH B 266 DISTANCE = 7.28 ANGSTROMS REMARK 525 HOH B 267 DISTANCE = 7.34 ANGSTROMS REMARK 525 HOH D 364 DISTANCE = 5.83 ANGSTROMS REMARK 525 HOH D 365 DISTANCE = 6.09 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 100 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 10 NE2 REMARK 620 2 HIS B 10 NE2 0.0 REMARK 620 3 ACT B 101 O 97.5 97.5 REMARK 620 4 ACT B 101 O 158.0 158.0 65.0 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN D 202 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 10 NE2 REMARK 620 2 HIS D 10 NE2 0.0 REMARK 620 3 HOH D 335 O 92.0 92.0 REMARK 620 4 HOH D 335 O 166.3 166.3 78.0 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN B 100 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue POL D 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN D 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3W7Y RELATED DB: PDB REMARK 900 SECOND HIGHEST RESOLUTION HUMAN RECOMBINANT INSULIN X-RAY STRUCTURE REMARK 900 RELATED ID: 4INS RELATED DB: PDB REMARK 900 PIG INSULIN STRUCTURE DBREF 5E7W A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 5E7W B 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 5E7W C 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 5E7W D 1 30 UNP P01308 INS_HUMAN 25 54 SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 B 30 THR PRO LYS THR SEQRES 1 C 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 C 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 D 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 D 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 D 30 THR PRO LYS THR HET ZN B 100 1 HET ACT B 101 4 HET POL D 201 12 HET ZN D 202 1 HETNAM ZN ZINC ION HETNAM ACT ACETATE ION HETNAM POL N-PROPANOL HETSYN POL 1-PROPONOL FORMUL 5 ZN 2(ZN 2+) FORMUL 6 ACT C2 H3 O2 1- FORMUL 7 POL C3 H8 O FORMUL 9 HOH *220(H2 O) HELIX 1 AA1 GLY A 1 SER A 9 1 9 HELIX 2 AA2 SER A 12 ASN A 18 1 7 HELIX 3 AA3 GLY B 8 GLY B 20 1 13 HELIX 4 AA4 GLU B 21 GLY B 23 5 3 HELIX 5 AA5 ILE C 2 CYS C 7 1 6 HELIX 6 AA6 SER C 12 GLU C 17 1 6 HELIX 7 AA7 ASN C 18 CYS C 20 5 3 HELIX 8 AA8 GLY D 8 GLY D 20 1 13 HELIX 9 AA9 GLU D 21 GLY D 23 5 3 SHEET 1 AA1 2 PHE B 24 TYR B 26 0 SHEET 2 AA1 2 PHE D 24 TYR D 26 -1 O TYR D 26 N PHE B 24 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.05 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.06 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.03 SSBOND 4 CYS C 6 CYS C 11 1555 1555 2.13 SSBOND 5 CYS C 7 CYS D 7 1555 1555 2.03 SSBOND 6 CYS C 20 CYS D 19 1555 1555 2.03 LINK NE2 HIS B 10 ZN ZN B 100 1555 1555 2.09 LINK NE2 HIS B 10 ZN ZN B 100 1555 2555 2.09 LINK ZN ZN B 100 O ACT B 101 1555 1555 2.09 LINK ZN ZN B 100 O ACT B 101 1555 2555 2.09 LINK NE2 HIS D 10 ZN ZN D 202 1555 1555 2.08 LINK NE2 HIS D 10 ZN ZN D 202 1555 2555 2.08 LINK ZN ZN D 202 O HOH D 335 1555 1555 2.23 LINK ZN ZN D 202 O HOH D 335 1555 2555 2.23 SITE 1 AC1 2 HIS B 10 ACT B 101 SITE 1 AC2 3 HIS B 10 ZN B 100 HOH B 202 SITE 1 AC3 10 ASN A 18 HOH A 110 GLY C 1 ILE C 2 SITE 2 AC3 10 TYR C 19 PHE D 25 THR D 27 THR D 30 SITE 3 AC3 10 HOH D 301 HOH D 323 SITE 1 AC4 2 HIS D 10 HOH D 335 CRYST1 81.820 81.820 33.850 90.00 90.00 120.00 H 3 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012222 0.007056 0.000000 0.00000 SCALE2 0.000000 0.014113 0.000000 0.00000 SCALE3 0.000000 0.000000 0.029542 0.00000